Publications

5808 Results

Gene expression profiling of phenotypically-defined hormone-receptor positive breast cancer: evidence for increased transcriptional activity of the insulin growth factor receptor pathway and other pathways

Authors
J Sparano;RG Gray;LJ Goldstein;BH Childs;D Brassard;R Bugarini;S Rowley;J Baker;S Shak;S Badve;FL Baehner;P Kenny;E Perez;LN Shulman;S Martino;G Sledge;NE Davidson
Journal / Conference
San Antonio Breast Cancer Symposium, abstract #5165, poster presentation
Year
2009
Research Committee(s)
Breast
Study Number(s)
E2197

Black race is associated with a worse outcome in patients with hormone receptor positive, HER2-normal breast cancer treated with adjuvant chemohormonal therapy

Authors
J Sparano;M Wang;V Stearns;S Martino;V Jones;E Perez;T Saphner;A Wolff;G Sledge;W Wood;NE Davidson
Journal / Conference
San Antonio Breast Cancer Symposium, abstract #37 (general session)
Year
2009
Research Committee(s)
Breast
Study Number(s)
E1199

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy [PMID19138424; PMC2667813]

Authors
JA Ajani;KA Winter;LL Gunderson;J Pederson;AB Benson;CR Thomas;RJ Mayer;MG Haddock;TA Rich;CG Willett
Journal / Conference
Journal of Clinical Oncology 27(7):1116-1121
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
R9811

Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on Selenium and Vitamin E Cancer Prevention Trial. PMID: 19528369

Authors
EA Platz;SM Lippman
Journal / Conference
Journal of Clinical Oncology 27(22):3569-3572
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Prostate-specific antigen and its role on the Prostate Cancer Prevention Trial

Authors
CM Tangen;PJ Goodman
Journal / Conference
Prostate Cancer Screening, 2nd edition, D. Ankerst, IM Thompson, C Tangen, eds., Humana Press, New York, Ch. 24, pp. 333-348
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator

Authors
DP Ankerst;IM Thompson
Journal / Conference
Prostate Cancer Screening, 2nd edition, DP Ankerst, IM Thompson, C Tangen, Eds., Humana Press, New York, Ch. 12, pp. 195-203.
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

The performance characteristics of prostate-specific antigen for prostate cancer screening

Authors
IM Thompson;DP Ankerst
Journal / Conference
Prostate Cancer Screening, 2nd editiion, DP Ankerst, IM Thompson, C Tangen, eds., Humana Press, New York, Ch. 6, pp. 61-70
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Selenium and vitamin E: interesting biology and dashed hope. PMID: 19244172

Authors
EA Klein
Journal / Conference
Journal of the National Cancer Institute 101(5):283-295
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention. PMID: 19213568

Authors
BK Dunn;A Ryan;L Ford
Journal / Conference
Recent Results in Cancer Research 181:183-193
Year
2009
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Fc gamma receptor 3a genotype predicts overall survival for follicular lymphoma patients treated on Southwest Oncology Group trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Authors
DO Persky;D Dornan;B Goldman;M LeBlanc;RM Braziel;RI Fisher;D Maloney;T Miller;OW Press;LM Rimsza
Journal / Conference
Blood 114:abst.#111 (ASH Annual Meeting, oral presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8809, S9800, S9911